{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-007723","form_type":"8-K","ticker":"ESLA","cik":"0001844417","company_name":"Estrella Immunopharma, Inc.","filed_at":"2024-01-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.943325+00:00","generated_at":"2026-06-06T15:13:39.421032+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Estrella Immunopharma authorizes up to $1M share repurchase","bullets":["Board authorized up to $1 million of common stock repurchases; no binding commitment.","Timing, amount and method of repurchases to be determined by market conditions.","CEO and CFO state authorization reflects confidence in Estrella's value and strategic direction.","Repurchase program covers stock traded on Nasdaq under ticker ESLA."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-007723","json":"https://secwatch.observer/filing/0001213900-24-007723.json","markdown":"https://secwatch.observer/filing/0001213900-24-007723.md","text":"https://secwatch.observer/filing/0001213900-24-007723.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1844417/000121390024007723/0001213900-24-007723-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1844417/000121390024007723/ea192451-8k_estrella.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T15:13:39.421032+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}